Acorda Therapeutics Drops In Pre-Market On FDA News
Acorda Therapeutics, Inc. (ACOR) is dropping during pre-market trading on Tuesday. The decline comes after the company said it received a refuse to file letter from the FDA regarding its New Drug Application for Fampridine-SR, a therapy being developed to improve walking ability in people with multiple sclerosis.
Fuqi International Inc. Rises in Pre-Market on Q4 Earnings
Fuqi International Inc.(FUQI) is on the rise in pre-market trading Tuesday on news of better-than-expected earnings for the fourth quarter.
Amylin Pharmaceuticals Inc. Up in Pre-Market on News of Successful Therapy Trial
Amylin Pharmaceuticals Inc. (AMLN) is up in pre-market trading Tuesday morning on news of positive results from a new diabetes therapy technique.